Mr. Speaker, with regard to part (a), there are approximately 50,000 to 60,000 stored samples in the Statistics Canada biobank from Canadians who have responded to the Canadian health measures survey and the Canadian COVID-19 antibody and health survey. All holdings are from consenting Canadians and most have contributed multiple samples.
The samples include blood: 59,100 Canadians respondents for a total of 417,400 samples. The initial blood sample is separated into many smaller samples, such as serum, plasma, whole blood and dried blood spots. The samples include urine: 33,200 Canadian respondents for a total of 121,700 samples. The initial urine sample is separated into many smaller urine samples. The samples include DNA: 10,800 Canadian respondents for a total of 10,800 samples. Additionally, the samples include saliva: 11,300 Canadian respondents for a total of 11,300 samples.
With regard to part (b)(i) less than a year, 2022: there are 27,800 samples from 16,500 Canadians. With regard to part (ii) one to three years, 2019-21: there are 114,200 samples from 12,700 Canadians. With regard to part (iii) over three years, 2007-18: there are 473,800 samples from 31,000 Canadians.
With regard to part (c)(i), samples are only used for research projects at Canadian facilities and with Canadian researchers. Project proposals go through an internal feasibility review by Statistics Canada experts, followed by a second review by an interdepartmental expert biobank advisory committee. The biobank advisory committee requires the following items to grant approval: an approved feasibility review, a completed proposal, research ethics board certificates and proof of funding for the project.
Statistics Canada must approve the researchers to work on the project. Only the targeted survey samples required for the approved projects and relevant data are shared. The samples at the biobank contain no identifiable data. The survey data is connected to the biospecimen sample results using a unique digital identifier. The survey data and samples must be stored and analyzed by the researchers in a protected physical and virtual environment that must meet Statistics Canada security requirements. Laboratory service agreements must be signed with all laboratories storing and analyzing the biobank samples and the same rules as stated above apply.
All biobank projects that have been approved are listed at this location: Biobank projects.
With regard to part (c)(ii), samples are stored at the National Microbiology Laboratory’s Biorepository, which is compliant with ISO 9001 regarding their quality management system: ISO - ISO 9001 and related standards — Quality management.
With regard to part (c)(iii), samples are destroyed by the reference laboratory after a sample is used for an approved research project. Canadian respondents can also request their samples be removed and destroyed at any time.
With regard to part (c)(iv), all information in the Statistics Canada biobank and the survey data is protected by the Statistics Act, the Privacy Act and the Access to Information Act. Collected samples undergo a thorough and strict labelling process. Only authorized Statistics Canada employees have access to samples and survey data. Data does not include personal information. Under the authority of the Statistics Act, samples and data in the Statistics Canada biobank will always be kept secure and confidential.
Internal standard operating procedures, SOPs, are established and followed for each step.
With regard to part (d), samples are stored in the Statistics Canada biobank until they no longer have scientific value or when a respondent requests their samples be removed and destroyed.
Samples can also be disposed of after they have been analyzed for a research project. The laboratory has one month to destroy the samples after Statistics Canada has notified to proceed with the destruction of the samples.
Visit the Statistics Canada Biobank website for more information.